AQS Insider Trading

Insider Ownership Percentage: 14.68%
Insider Buying (Last 12 Months): C$0.00
Insider Selling (Last 12 Months): C$0.00

Aequus Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Aequus Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aequus Pharmaceuticals Share Price & Price History

Current Price: C$0.03
Price Change: Price Increase of +0.005 (25.00%)
As of 05/22/2024 06:13 PM ET

This chart shows the closing price history over time for AQS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Aequus Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/30/2022Doug JanzenDirectorBuy285,000C$0.04C$11,400.0012,553,800
11/20/2022Doug JanzenDirectorBuy115,000C$0.03C$3,450.0012,268,800
7/25/2022Marc LustigDirectorBuy64,000C$0.07C$4,480.00214,000
7/21/2022Marc LustigDirectorBuy4,000C$0.07C$280.00124,000
7/19/2022Doug JanzenDirectorBuy99,000C$0.07C$6,930.0012,052,800
9/1/2021Doug JanzenDirectorBuy500,000C$0.15C$72,500.0011,958,800
See Full Table

SEC Filings (Institutional Ownership Changes) for Aequus Pharmaceuticals (CVE:AQS)

Aequus Pharmaceuticals logo
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Read More on Aequus Pharmaceuticals

Today's Range

Now: C$0.03
Low: C$0.03
High: C$0.03

50 Day Range

MA: C$0.02
Low: C$0.01
High: C$0.03

52 Week Range

Now: C$0.03
Low: C$0.01
High: C$0.06

Volume

200,000 shs

Average Volume

232,632 shs

Market Capitalization

C$3.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.29

Who are the company insiders with the largest holdings of Aequus Pharmaceuticals?

Aequus Pharmaceuticals' top insider shareholders include:
  1. Doug Janzen (Director)
  2. Marc Lustig (Director)
Learn More about top insider investors at Aequus Pharmaceuticals.